Top

Published in:

01-02-2016 | Pictorial Essay

Common and uncommon pitfalls in pancreatic imaging: it is not always cancer

Authors: F. Vernuccio, A. A. Borhani, M. Dioguardi Burgio, M. Midiri, A. Furlan, G. Brancatelli

Published in: Abdominal Radiology | Issue 2/2016

Abstract

Despite advances in multimodality imaging of pancreas, there is still overlap between imaging findings of several pancreatic/peripancreatic disease processes. Pancreatic and peripancreatic non-neoplastic entities may mimic primary pancreatic neoplasms on ultrasound, CT, and MRI. On the other hand, primary pancreatic cancer may be overlooked on imaging because of technical and inherent factors. The purpose of this pictorial review is to describe and illustrate pancreatic imaging pitfalls and highlight the basic radiological features for proper differential diagnosis.

Matos C, Cappeliez O, Winant C, et al. (2002) MR imaging of the pancreas: a pictorial tour. Radiographics 22(1):e2. doi:10.1148/radiographics.22.1.g02jae2e2 CrossRefPubMed

McNulty NJ, Francis IR, Platt JF, et al. (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220(1):97–102. doi:10.1148/radiology.220.1.r01jl1897 CrossRefPubMed

Fattahi R, Balci NC, Perman WH, et al. (2009) Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging 29(2):350–356. doi:10.1002/jmri.21651 CrossRefPubMed

Sandrasegaran K, Lin C, Akisik FM, Tann M (2010) State-of-the-art pancreatic MRI. AJR Am J Roentgenol 195(1):42–53. doi:10.2214/ajr.195.3_supplement.0s42 CrossRefPubMed

Dimcevski G, Erchinger FG, Havre R, Gilja OH (2013) Ultrasonography in diagnosing chronic pancreatitis: new aspects. World J Gastroenterol 19(42):7247–7257. doi:10.3748/wjg.v19.i42.7247 PubMedCentralCrossRefPubMed

Atri M, Nazarnia S, Mehio A, Reinhold C, Bret PM (1994) Hypoechogenic embryologic ventral aspect of the head and uncinate process of the pancreas: in vitro correlation of US with histopathologic findings. Radiology 190(2):441–444. doi:10.1148/radiology.190.2.8284396 CrossRefPubMed

Al-Hawary MM, Kaza RK, Azar SF, Ruma JA, Francis IR (2013) Mimics of pancreatic ductal adenocarcinoma. Cancer Imaging 13(3):342–349. doi:10.1102/1470-7330.2013.9012 PubMedCentralCrossRefPubMed

Kim JK, Altun E, Elias J Jr, et al. (2007) Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 26(2):313–322. doi:10.1002/jmri.21010 CrossRefPubMed

Ichikawa T, Sou H, Araki T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221(1):107–116. doi:10.1148/radiol.2211001157 CrossRefPubMed

10.

Lee SS, Byun JH, Park BJ, et al. (2008) Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging 28(4):928–936. doi:10.1002/jmri.21508 CrossRefPubMed

11.

Gerritsen A, Molenaar IQ, Bollen TL, et al. (2014) Preoperative characteristics of patients with presumed pancreatic cancer but ultimately benign disease: a multicenter series of 344 pancreatoduodenectomies. Ann Surg Oncol 21(12):3999–4006. doi:10.1245/s10434-014-3810-7 CrossRefPubMed

12.

To’o KJ, Raman SS, Yu NC, et al. (2005) Pancreatic and peripancreatic diseases mimicking primary pancreatic neoplasia. Radiographics 25(4):949–965. doi:10.1148/rg.254045167 CrossRefPubMed

13.

Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R (2010) Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24(3):349–358. doi:10.1016/j.bpg.2010.02.007 CrossRefPubMed

14.

Matsubayashi H, Kakushima N, Takizawa K, et al. (2014) Diagnosis of autoimmune pancreatitis. World J Gastroenterol 20(44):16559–16569. doi:10.3748/wjg.v20.i44.16559 PubMedCentralCrossRefPubMed

15.

Manfredi R, Graziani R, Cicero C, et al. (2008) Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 247(2):435–443. doi:10.1148/radiol.2472070598 CrossRefPubMed

16.

Negrelli R, Manfredi R, Pedrinolla B, et al. (2015) Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings. Eur Radiol 25(2):359–367. doi:10.1007/s00330-014-3371-y CrossRefPubMed

17.

Hur BY, Lee JM, Lee JE, et al. (2012) Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging 36(1):188–197. doi:10.1002/jmri.23609 CrossRefPubMed

18.

Borghei P, Sokhandon F, Shirkhoda A, Morgan DE (2013) Anomalies, anatomic variants, and sources of diagnostic pitfalls in pancreatic imaging. Radiology 266(1):28–36. doi:10.1148/radiol.12112469 CrossRefPubMed

19.

Griffin N, Yu D, Alexander Grant L (2013) Magnetic resonance cholangiopancreatography: pearls, pitfalls, and pathology. Semin Ultrasound CT MR 34(1):32–43. doi:10.1053/j.sult.2012.11.003 CrossRefPubMed

20.

Katz DS, Hines J, Math KR, et al. (1999) Using CT to reveal fat-containing abnormalities of the pancreas. AJR Am J Roentgenol 172(2):393–396. doi:10.2214/ajr.172.2.9930790 CrossRefPubMed

21.

Pokharel SS, Macura KJ, Kamel IR, Zaheer A (2013) Current MR imaging lipid detection techniques for diagnosis of lesions in the abdomen and pelvis. Radiographics 33(3):681–702. doi:10.1148/rg.333125068 CrossRefPubMed

22.

Isserow JA, Siegelman ES, Mammone J (1999) Focal fatty infiltration of the pancreas: MR characterization with chemical shift imaging. AJR Am J Roentgenol 173(5):1263–1265. doi:10.2214/ajr.173.5.10541101 CrossRefPubMed

23.

Klein KA, Stephens DH, Welch TJ (1998) CT characteristics of metastatic disease of the pancreas. Radiographics 18(2):369–378. doi:10.1148/radiographics.18.2.9536484 CrossRefPubMed

24.

Ng CS, Loyer EM, Iyer RB, et al. (1999) Metastases to the pancreas from renal cell carcinoma: findings on three-phase contrast-enhanced helical CT. AJR Am J Roentgenol 172(6):1555–1559. doi:10.2214/ajr.172.6.10350288 CrossRefPubMed

25.

Kim SH, Lee JM, Han JK, et al. (2008) Intrapancreatic accessory spleen: findings on MR Imaging, CT, US and scintigraphy, and the pathologic analysis. Korean J Radiol 9(2):162–174. doi:10.3348/kjr.2008.9.2.162 PubMedCentralCrossRefPubMed

26.

Unver Dogan N, Uysal II, Demirci S, Dogan KH, Kolcu G (2011) Accessory spleens at autopsy. Clin Anat 24(6):757–762. doi:10.1002/ca.21146 CrossRefPubMed

27.

Kawamoto S, Johnson PT, Hall H, et al. (2012) Intrapancreatic accessory spleen: CT appearance and differential diagnosis. Abdom Imaging 37(5):812–827. doi:10.1007/s00261-011-9830-x CrossRefPubMed

28.

Coquia SF, Kawamoto S, Zaheer A, et al. (2014) Intrapancreatic accessory spleen: possibilities of computed tomography in differentiation from nonfunctioning pancreatic neuroendocrine tumor. J Comput Assist Tomogr 38(6):874–878. doi:10.1097/RCT.0000000000000127 PubMedCentralCrossRefPubMed

29.

Jang KM, Kim SH, Song KD, et al. (2015) Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas: value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT. Clin Radiol 70(2):153–160. doi:10.1016/j.crad.2014.10.010 CrossRefPubMed

30.

Kalb B, Sarmiento JM, Kooby DA, Adsay NV, Martin DR (2009) MR imaging of cystic lesions of the pancreas. Radiographics 29(6):1749–1765. doi:10.1148/rg.296095506 CrossRefPubMed

31.

Palmucci S, Mauro LA, Milone P, et al. (2010) Diagnosis of ruptured superior mesenteric artery aneurysm mimicking a pancreatic mass. World J Gastroenterol 16(18):2298–2301PubMedCentralCrossRefPubMed

32.

Messina LM, Shanley CJ (1997) Visceral artery aneurysms. Surg Clin N Am 77(2):425–442CrossRefPubMed

33.

Vilgrain V, Condat B, O’Toole D, et al. (2009) Pancreatic portal cavernoma in patients with cavernous transformation of the portal vein: MR findings. Eur Radiol 19(11):2608–2613. doi:10.1007/s00330-009-1459-6 CrossRefPubMed

34.

Macaluso FS, Maida M, Dioguardi Burgio M, Brancatelli G (2013) Education and imaging: hepatobiliary and pancreatic—portal hypertensive biliopathy presenting as acute cholangitis. J Gastroenterol Hepatol 28(8):1257. doi:10.1111/jgh.12295 CrossRefPubMed

35.

Lawler LP, Horton KM, Fishman EK (2003) Peripancreatic masses that simulate pancreatic disease: spectrum of disease and role of CT. Radiographics 23(5):1117–1131. doi:10.1148/rg.235035013 CrossRefPubMed

36.

Hariri A, Siegelman SS, Hruban RH (2005) Duodenal diverticulum mimicking a cystic pancreatic neoplasm. Br J Radiol 78(930):562–564. doi:10.1259/bjr/52543195 CrossRefPubMed

37.

Moriya T, Kimura W, Hirai I, et al. (2012) Pancreatic schwannoma: case report and an updated 30-year review of the literature yielding 47 cases. World J Gastroenterol 18(13):1538–1544. doi:10.3748/wjg.v18.i13.1538 PubMedCentralCrossRefPubMed

38.

Ahn SS, Kim MJ, Choi JY, et al. (2009) Indicative findings of pancreatic cancer in prediagnostic CT. Eur Radiol 19(10):2448–2455. doi:10.1007/s00330-009-1422-6 CrossRefPubMed

39.

Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224(3):764–768. doi:10.1148/radiol.2243011284 CrossRefPubMed

40.

Gangi S, Fletcher JG, Nathan MA, et al. (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 182(4):897–903. doi:10.2214/ajr.182.4.1820897 CrossRefPubMed

41.

Ichikawa T, Haradome H, Hachiya J, et al. (1997) Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 202(3):655–662. doi:10.1148/radiology.202.3.9051012 CrossRefPubMed

42.

Bronstein YL, Loyer EM, Kaur H, et al. (2004) Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 182(3):619–623. doi:10.2214/ajr.182.3.1820619 CrossRefPubMed

Title: Common and uncommon pitfalls in pancreatic imaging: it is not always cancer
Authors: F. Vernuccio
A. A. Borhani
M. Dioguardi Burgio
M. Midiri
A. Furlan
G. Brancatelli
Publication date: 01-02-2016
Publisher: Springer US
Published in: Abdominal Radiology / Issue 2/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-015-0557-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2016

Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients

The stained glass window appearance

Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy

The “molar tooth” sign

The “Nubbin” Sign

Comparison of tumor vascularity and hemodynamics in three rat hepatoma models

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials